Atox Bio is harnessing the power of immunomodulation to develop novel treatments for a number of unmet medical needs. In addition to necrotizing soft tissue infections, the company’s scientific platform holds potential across a wide range of other indications from sepsis to burns. The common element is an unwavering commitment to the highest scientific standards with the goal of improving the lives of patients.
